AxioMx Inc. Develops Novel Synthetic Antibody Library
October 6, 2014
Branford, Conn. -- AxioMx Inc., a leader in recombinant antibody technologies, today announced the successful completion of research funded by a National Institute of Health (NIH) SBIR grant to develop a novel library for selection of affinity reagents. Under the research, AxioMx created a highly diverse synthetic phage-display antibody library. “We are refining the affinity [...]
Phenomenex Introduces First Synthetic Sorbent for Simplified Liquid Extraction (SLE)
October 6, 2014
Torrance, CA -– Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Novum Simplified Liquid Extraction (SLE), a novel, synthetic alternative to traditional diatomaceous earth SLE (also known as supported liquid extraction) products and a simplified approach to traditional liquid-liquid extraction (LLE). Extraction techniques used prior [...]
LabVantage Solutions Launches a New Major Version of its LIMS
October 6, 2014
Somerset, NJ –– LabVantage Solutions announced the immediate availability of LabVantage 7 at its annual user conference. LabVantage 7 provides significantly improved user experience as well as capabilities that make it easier to enable process optimization. LabVantage 7 was built with extensive customer feedback that was backed up by a beta testing program. LabVantage 7 [...]
BioTime, Inc. and Subsidiaries to Raise $31 Million Through Sales of Common Shares
October 6, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT:BTX) today announced that it has agreed to sell up to an aggregate of 9,431,398 common shares, in a registered direct offering at an offering price of $3.12 per share. The price per share was the closing price of our common shares on the NYSE MKT on October 2, [...]
BIOFORCE NANOSCIENCES, INC. BEGINS SALES OF THEIR NEW NANO ENABLER
October 6, 2014
CHICAGO, IL -– BioForce Nanosciences, Inc. (BioForce) recently completed the installation of the newest version of its groundbreaking Nano eNabler Benchtop Molecular Printer. With increased optical resolution, state of the art computer hardware and Windows 8.1 operating system, the Nano eNabler will provide expanded capabilities for the research market. The Nano eNabler is the only [...]
October 6, 2014
Qbic Arkiv Fund, Foundation Majoie and SOFI invest 2.0 million EUR in UGent spin-off Biogazelle, a company that offers software and laboratory services for gene expression analysis. Biogazelle will primarily use the investment to further develop its research on therapeutic RNA targets for specific cancer types, and to expand its commercial activities. Biogazelle (www.biogazelle.com) was [...]
AB SCIEX Proteomics Scientist Again Wins HUPO 2014 Science and Technology Award
October 6, 2014
Framingham, MA -- AB SCIEX, a global leader in life science analytical technologies, announced that Dr. Subhasish "Babu" Purkayastha, Director, R&D at AB SCIEX, has been awarded the Human Proteome Organization (HUPO) Science and Technology Award for efforts in commercialization of isobaric labeling for protein quantification with the development of iTRAQ chemistries. The award further [...]
Michael H. Mulroy and Stephen L. Cartt Joining BioTime Board of Directors
October 6, 2014
ALAMEDA, Calif. -- BioTime, Inc. (NYSE MKT:BTX) announced today that Michael H. Mulroy and Stephen L. Cartt are joining its Board of Directors. Mr. Mulroy has been appointed to the Board to fill a vacancy and Mr. Cartt has been nominated for election to the Board at the Company’s upcoming annual shareholders’ meeting, which will [...]
Perten Instruments appoints General Manager for Canada
October 6, 2014
Perten Instruments announces the appointment of Michael Reimer as General Manager for Perten’s Canadian operations. Michael will be immediately tasked with opening a new office in the Winnipeg area. Mike brings extensive experience in the food and agricultural business. He worked in both the Oilseed and Pulse Research Labs at the Canadian Grain Commission and [...]
John Flannery to Lead GE Healthcare
October 6, 2014
FAIRFIELD, CT. –– GE Chairman and CEO Jeff Immelt announced today the appointment of John Flannery as president and CEO of GE Healthcare succeeding John Dineen, who is leaving GE. The appointment is effective immediately. Flannery, 53, most recently was senior vice president of business development for GE. In the past year, Flannery led business [...]
